BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present Overview, Clinical Trial Update at Upcoming Benzinga Conference
Dec 3, 2020
Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it will present at the Benzinga Global Small Cap Conference taking place virtually on Dec. 8-9, 2020. Genprex’s president and CEO, Rodney Varner, will deliver a company overview that includes recent progress the company has made on its upcoming Acclaim-1 clinical trial. Varner’s presentation is scheduled to begin at 2:30 p.m. EST on Tuesday, Dec. 8. Investors and other interested parties should visit https://ibn.fm/VdFrh to register for the event.
To view the full press release, visit https://ibn.fm/EPK3b
About Genprex Inc.
Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, “REQORSA(TM)” (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for REQORSA for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s web site atwww.Genprex.com.
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
The Lucas Museum’s Architect Wants to Help You Escape From Reality
Ma Yansong, China’s reigning starchitect, lets his buildings wrapped in nature do the shouting.
Newcastle University under fire over Anant Ambani professorship amid Vantara scandal
Britain’s Newcastle University faced criticism on Thursday for awarding a sustainability professorship to Anant Ambani, the son of Asia’s richest man and owner of a scandal-hit giant wildlife centre in India. Vantara, which calls itself the world’s largest rescue centre, last month announced a major reset of its procedures following concerns about its rapid and vast acquisition of animals from around the world, including endangered species. Newcastle University said on September 14, it awarded...
Ukraine’s POW transfer reveal deals North Korea a propaganda blow
Ukrainian President Volodymyr Zelensky has put North Korea in a propaganda bind, analysts say, by publicly revealing that Kyiv recently transferred two North Korean prisoners of war to South Korea. The disclosure – made during Zelensky’s address to the UN General Assembly on Wednesday – directly challenges Pyongyang’s narrative that its soldiers fighting alongside Russian forces choose death over surrendering. North Korea is unlikely to acknowledge the transfer publicly, but may strengthen...
China to Send Pandas to Zoo Atlanta, Xi Says
Xi Jinping, China’s leader, said two pandas would arrive soon at Zoo Atlanta. Panda diplomacy has been a cornerstone of U.S.-China relations.
Ukraine Sent Two North Korean P.O.W.s to South Korea, Zelensky Says
President Volodymyr Zelensky of Ukraine said one soldier tried to kill himself when he was captured. “This is how they raise people in the North,” he said.
The Story of Bhutan’s UN Membership
55 years ago, Bhutan joined the United Nations – with a rare show of support from bitter rivals.
Who Is Indigenous? The Politics of Tribal Identity Terminology in India and Bangladesh
Tribal people in South Asia prefer being called adivasi or original inhabitants, but nationalist forces in India and Bangladesh oppose it for different reasons.
India’s Semiconductor Journey: Old Designer, New Producer
India already has the design talent; what it needs is to turn this talent into Indian-owned companies, and to build the supplier base its fabs lack.
Singapore’s finance firms pledge to train 80,000 local staff in AI skills
Singapore’s major financial institutions have pledged to train more than 80,000 local employees in AI skills as the country moves to cushion white-collar workers from potential job disruption. A pioneer batch of 23 banks, insurers and asset managers has committed to train all their Singapore staff by 2028, and more than half of them have already gone through programmes recognised by an industry association, according to Deputy Prime Minister Gan Kim Yong. The firms would also study how jobs were...
Constitutional Reform as the Lee Jae-myung Administration’s Political Watershed
South Koreans have long discussed changing the way the presidency is set up. Should it – and can it – happen now?
Takaichi’s Pre-emptive Diplomacy: What Japan Needs From the Trump-Xi Summit
Prime Minister Takaichi made Tokyo’s concerns clear to Trump before Xi Jinping arrived in Washington. Will that actually impact the summit?
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.